KIDS
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Trades at a low multiple of book value, but lacks earnings to support a traditional valuation.
- Low Price/Book ratio (1.16)
- Negative P/E
- No Graham Number available due to lack of earnings
Growth is present in top-line revenue, but has not yet trickled down to the bottom line.
- Double-digit revenue growth (17%)
- Positive analyst target price ($24.89)
- Negative forward P/E
- Unproven path to profitability
Historical performance shows a persistent failure to generate shareholder value.
- Consistent earnings surprises
- 5-year return of -67.6%
- Consistent quarterly losses
Strong balance sheet liquidity masks deep operational inefficiency (F-Score).
- Low Debt/Equity
- High Quick Ratio (2.48)
- Piotroski F-Score 1/9
- Negative ROE and ROA
Non-dividend paying growth/speculative stock.
- No dividend paid
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for KIDS and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
KIDS
OrthoPediatrics Corp.
Primary
|
-67.6% | -67.3% | -25.3% | -2.0% | -10.3% | -0.6% |
|
ENTA
Enanta Pharmaceuticals, Inc.
Peer
|
-71.8% | -64.9% | +208.7% | +21.9% | -0.9% | +6.2% |
|
AGL
agilon health, inc.
Peer
|
-96.8% | -95.0% | -73.1% | -51.9% | +41.4% | -2.8% |
|
AKBA
Akebia Therapeutics, Inc.
Peer
|
-59.4% | +113.8% | -13.6% | -50.5% | -5.8% | +15.0% |
|
AUNA
Auna SA
Peer
|
-41.0% | -41.0% | -30.8% | -9.7% | +21.7% | +22.2% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
KIDS
OrthoPediatrics Corp.
|
BEARISH | $403.7M | - | -11.3% | -16.8% | $15.97 | |
|
ENTA
Enanta Pharmaceuticals, Inc.
|
BEARISH | $399.6M | - | -60.0% | -106.8% | $13.77 | Compare |
|
AGL
agilon health, inc.
|
BEARISH | $410.85M | - | -73.3% | -5.2% | $0.99 | Compare |
|
AKBA
Akebia Therapeutics, Inc.
|
BEARISH | $391.1M | - | -% | -2.3% | $1.46 | Compare |
|
AUNA
Auna SA
|
NEUTRAL | $418.91M | 5.78 | 11.4% | 4.3% | $5.66 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | HITE FRED L | Chief Operating Officer | Sale | 12,993 | $224,129 |
| 2026-03-16 | BAILEY DAVID R | Chief Executive Officer | Sale | 19,535 | $336,979 |
| 2026-03-16 | GERRITZEN DANIEL J. | General Counsel | Sale | 8,614 | $148,592 |
| 2026-03-16 | ODLE GREGORY A | Officer | Sale | 8,433 | $145,469 |
| 2026-03-16 | HAUSER JOSEPH W | Officer | Sale | 8,596 | $148,281 |
| 2026-03-13 | HITE FRED L | Chief Operating Officer | Stock Award | 77,405 | - |
| 2026-03-13 | GERRITZEN DANIEL J. | General Counsel | Stock Award | 47,380 | - |
| 2026-03-13 | ODLE GREGORY A | Officer | Stock Award | 47,380 | - |
| 2026-03-13 | HAUSER JOSEPH W | Officer | Stock Award | 65,700 | - |
| 2025-12-29 | BAILEY DAVID R | Chief Executive Officer | Gift | 1,600 | - |
| 2025-11-10 | FISCHER KELLY LAINE | Director | Stock Award | 4,345 | - |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning KIDS from our newsroom.